PMC:7556165 / 53087-53245 JSONTXT

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T318","span":{"begin":102,"end":106},"obj":"Species"},{"id":"T319","span":{"begin":119,"end":129},"obj":"Species"},{"id":"T320","span":{"begin":119,"end":123},"obj":"Species"}],"attributes":[{"id":"A318","pred":"ncbi_taxonomy_id","subj":"T318","obj":"NCBItxid:694009"},{"id":"A319","pred":"ncbi_taxonomy_id","subj":"T319","obj":"NCBItxid:2697049"},{"id":"A320","pred":"ncbi_taxonomy_id","subj":"T320","obj":"NCBItxid:694009"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"to use ACE2 for cell entry (Hofmann et al., 2005), although its S1 sequence is rather dissimilar from SARS (23.4%) and SARS-CoV-2 (29.2%). In spite of this, t"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1484","span":{"begin":7,"end":11},"obj":"Gene"},{"id":"1493","span":{"begin":119,"end":129},"obj":"Species"}],"attributes":[{"id":"A1484","pred":"pubann:denotes","subj":"1484","obj":"Gene:59272"},{"id":"A1493","pred":"pubann:denotes","subj":"1493","obj":"Tax:2697049"}],"text":"to use ACE2 for cell entry (Hofmann et al., 2005), although its S1 sequence is rather dissimilar from SARS (23.4%) and SARS-CoV-2 (29.2%). In spite of this, t"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T5669","span":{"begin":7,"end":11},"obj":"Protein"}],"attributes":[{"id":"A5669","pred":"uniprot_id","subj":"T5669","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"to use ACE2 for cell entry (Hofmann et al., 2005), although its S1 sequence is rather dissimilar from SARS (23.4%) and SARS-CoV-2 (29.2%). In spite of this, t"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T204","span":{"begin":16,"end":20},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"to use ACE2 for cell entry (Hofmann et al., 2005), although its S1 sequence is rather dissimilar from SARS (23.4%) and SARS-CoV-2 (29.2%). In spite of this, t"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T395","span":{"begin":16,"end":20},"obj":"Body_part"}],"attributes":[{"id":"A395","pred":"fma_id","subj":"T395","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"to use ACE2 for cell entry (Hofmann et al., 2005), although its S1 sequence is rather dissimilar from SARS (23.4%) and SARS-CoV-2 (29.2%). In spite of this, t"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T287","span":{"begin":102,"end":106},"obj":"Disease"},{"id":"T288","span":{"begin":119,"end":129},"obj":"Disease"},{"id":"T289","span":{"begin":119,"end":123},"obj":"Disease"}],"attributes":[{"id":"A287","pred":"mondo_id","subj":"T287","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A288","pred":"mondo_id","subj":"T288","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A289","pred":"mondo_id","subj":"T289","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"to use ACE2 for cell entry (Hofmann et al., 2005), although its S1 sequence is rather dissimilar from SARS (23.4%) and SARS-CoV-2 (29.2%). In spite of this, t"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1484","span":{"begin":7,"end":11},"obj":"Gene"},{"id":"1493","span":{"begin":119,"end":129},"obj":"Species"}],"attributes":[{"id":"A1484","pred":"tao:has_database_id","subj":"1484","obj":"Gene:59272"},{"id":"A1493","pred":"tao:has_database_id","subj":"1493","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"to use ACE2 for cell entry (Hofmann et al., 2005), although its S1 sequence is rather dissimilar from SARS (23.4%) and SARS-CoV-2 (29.2%). In spite of this, t"}